George B. Abercrombie, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 13,334 shares at $13.90 ($185K) on 2021-05-24, disclosed to the SEC on 2021-05-26.
Open-market sale of $185k BCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.90 | 6,667 | $93K | 50.0% |
| 2 | $13.90 | 6,667 | $93K | 50.0% |
| Total | $13.90 avg | 13,334 | $185K | 100% |
| Filing → |
| BCRX | SELL | 2021-11-17 | $61K | — | Filing → |
| BCRX | SELL | 2021-09-17 | $75K | — | Filing → |
| BCRX | SELL | 2021-09-14 | $1.1M | — | Filing → |